Attached files
| file | filename |
|---|---|
| EX-21 - EX-21 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex21.htm |
| EX-10.12 - EX-10.12 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex10d12.htm |
| EX-32.1 - EX-32.1 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex32d1.htm |
| EX-31.1 - EX-31.1 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex31d1.htm |
| EX-10.10 - EX-10.10 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex10d10.htm |
| EX-10.13 - EX-10.13 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex10d13.htm |
| EX-10.14 - EX-10.14 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex10d14.htm |
| EX-10.8 - EX-10.8 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex10d8.htm |
| EX-31.2 - EX-31.2 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex31d2.htm |
| EX-10.11 - EX-10.11 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex10d11.htm |
| 10-K - 10-K - SYNERGY PHARMACEUTICALS, INC. | a15-23224_110k.htm |
| EX-23 - EX-23 - SYNERGY PHARMACEUTICALS, INC. | a15-23224_1ex23.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Synergy Pharmaceuticals Inc. (the “Company”) on Form 10-K for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gary Sender, Executive Vice President, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
February 25, 2016 |
/s/ GARY SENDER |
|
|
Gary Sender |
|
|
Executive Vice President, Chief Financial Officer |